B-D-Galactose

SCHEMBL6517119

O=[N+]([O-])c1ccccc1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

	gene	UniProt	supporting neighbours	confidence
▸	SLC5A1	P13866	1/20	0.45

▸	GRK6	P43250	2/20	0.44

▸	CYP1A2	P05177	1/20	0.44

▸	NFKB1	P19838	1/20	0.44

▸	THPO	P40225	1/20	0.44

▸	ALDH1A1	P00352	1/20	0.44

▸	PMP22	Q01453	1/20	0.44

▸	CA12	O43570	1/20	0.43

▸	CA1	P00915	1/20	0.43

▸	CA2	P00918	1/20	0.43

▸	CA9	Q16790	1/20	0.43

▸	HK1	P19367	1/20	0.43

▸	HK2	P52789	1/20	0.43

▸	SLC28A3	Q9HAS3	1/20	0.41

▸	GPR35	Q9HC97	1/20	0.41

▸	SLC29A1	Q99808	1/20	0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
D-Galactose SCHEMBL4925625	1.00	SLC5A1 (0.45)	SLC5A1GRK6CYP1A2NFKB1THPO
B-D-Galactose SCHEMBL27837607	1.00	SLC5A1 (0.45)	SLC5A1GRK6CYP1A2NFKB1THPO
Beta-D-Glucose SCHEMBL28279621	1.00	SLC5A1 (0.45)	SLC5A1GRK6CYP1A2NFKB1THPO
B-D-Galactose SCHEMBL27996398	1.00	SLC5A1 (0.45)	SLC5A1GRK6CYP1A2NFKB1THPO
B-D-Galactose SCHEMBL2029537	1.00	SLC5A1 (0.45)	SLC5A1GRK6CYP1A2NFKB1THPO
B-D-Galactose SCHEMBL28038798	0.92	CYP1A2 (0.46)	SLC5A1CYP1A2NFKB1THPOALDH1A1
Nitrophenolate SCHEMBL9283777	0.88	GRK6 (0.42)	SLC5A1GRK6CYP1A2NFKB1THPO
Nitrophenolate SCHEMBL28338632	0.83	FBP1 (0.47)	CA12CA1CA2CA9
B-D-Galactose SCHEMBL28572410	0.81	HK1 (0.51)	CYP1A2NFKB1THPOALDH1A1PMP22
B-D-Galactose SCHEMBL22041578	0.81	HK1 (0.51)	CYP1A2NFKB1THPOALDH1A1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20050019923-A1	Dendrimers for use in targeted delivery	UNIVERSITY COLLEGE LONDON (GB)	2005-01-27	—	—	US	disclosed